Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
193,048,484
-
Shares change
-
+15,551,010
-
Total reported value, excl. options
-
$8,445,124,761
-
Value change
-
+$672,301,180
-
Put/Call ratio
-
115%
-
Number of buys
-
166
-
Number of sells
-
87
-
Price
-
$43.74
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2024
As of 31 Dec 2024 Revolution Medicines, Inc. - Common Stock (RVMD) had 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 193,048,484 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, Nextech Invest Ltd., FMR LLC, Paradigm Biocapital Advisors LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 279 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.